Semax first-time review: separating real effects from hype

What did @kek_drystan actually say?

The creator tried semax for the first time at 0.5 mg, felt nothing, and plans to increase the dose to 0.7 mg or 1 mg. Their core claim is that semax is "pretty much like a replacement for Adderall" based on its reputation for helping with "learning, brain clarity." They also framed no noticeable effect at 0.5 mg as a dosing problem rather than a signal about the compound itself.

That framing deserves scrutiny. Reporting zero subjective effect after a single dose of an understudied peptide, then planning to escalate the dose, is a pattern that gets people into trouble with compounds that have real pharmacological activity. The "I didn't feel shit" conclusion being met with "I'll just take more" is worth examining carefully before anyone else follows this logic.

Does the science back this up?

The evidence base for semax in healthy humans is thin. Most of the published research comes from Russian institutions and focuses on neurological patients, not cognitive enhancement in healthy people. What exists is intriguing but nowhere near enough to support the "Adderall replacement" framing.

Semax is a synthetic heptapeptide derived from ACTH(4-7) that appears to stimulate BDNF production and modulate dopaminergic and serotonergic systems. Dolotov et al. (2006, Journal of Molecular Neuroscience) showed semax increased BDNF expression in rat brain tissue. Shadrina et al. (2010, Journal of Molecular Neuroscience) found neuroprotective effects in ischemic stroke models. These are animal or clinical-disease studies. The leap to "works like Adderall in a healthy person studying for exams" is not supported by that literature. Amphetamine-based medications like Adderall work through dopamine and norepinephrine reuptake inhibition, a completely different mechanism with a completely different evidence profile in healthy cognition research.

What did they get wrong (or right)?

The "Adderall replacement" claim is misleading and potentially dangerous framing. Semax is not a replacement for any prescription medication, and calling it one understates both the lack of human evidence for semax and the seriousness of ADHD as a condition requiring proper clinical evaluation.

That said, the creator got one thing right by accident: 0.5 mg intranasal is within the range used in some of the Russian clinical literature for acute dosing, so they did not start at a reckless dose. But "I'll go higher until something happens" is not a responsible framework for dose-finding with a compound that has limited human safety data outside of clinical settings.

They also deserve credit for honest reporting. "I didn't notice anything" is exactly the kind of non-dramatic, first-person account that is actually more useful than the breathless nootropic hype that dominates this content category. The problem is the conclusion they draw from it.

What should you actually know?

Semax is not approved by the FDA and is not a regulated medication in the United States. It is sold as a research compound. Comparing it to Adderall, a Schedule II controlled substance with decades of clinical data, glosses over a massive evidentiary gap.

If you are considering cognitive enhancement, the honest answer from the current literature is that almost nothing has a strong evidence base in healthy adults. Fond et al. (2015, European Neuropsychopharmacology) reviewed cognitive enhancement strategies and found most showed modest or inconsistent effects in non-impaired populations. Semax is even further down that evidence hierarchy than the compounds reviewed there.

Dosing based on what "some people say" in forums is also not a sound strategy. Peptide purity, storage, and administration route all affect bioavailability in ways that make anecdotal dose comparisons unreliable. Anyone actually interested in peptide therapy should be working with a licensed clinician who can order labs, monitor response, and account for individual variation.

The bottom line

One person noticing nothing after a single dose of semax tells you almost nothing about the compound. It is not evidence you need a higher dose. It is also not evidence the compound does not work. It is just one data point from one person on one day, which is the fundamental limitation of n=1 self-experimentation presented as review content. The science on semax is genuinely interesting in certain clinical contexts. The "Adderall replacement" framing, though, is not supported by that science and should not be taken at face value.